No definition recorded for this entity.
Wiki pages (5)
SciDEX wiki entries that cover this entity. Different pages may focus on the gene, protein, or disease aspects of the same canonical id.
- Liver-Brain Neurodegeneration Axis
Hepatic Encephalopathy ### Pathophysiology Hepatic encephalopathy (HE) is the syndrome of neuropsychiatric
Read more → - CIDEB — Cell Death-Inducing DFFA-Like Effector B
hepatic lipid burden - **Exercise**: Enhances hepatic lipid oxidation - **Weight management
Read more → - wilsons-disease
hepatitis - Cirrhosis (micronodular) - Fulminant hepatic failure - Asymptomatic hepatomegaly Neurological symptoms
Read more → - GPT - Alanine Transaminase (ALT)
hepatic gluconeogenesis with peripheral tissue metabolism. ### Enzyme Characteristics | Property | Value
Read more → - Liver-Brain Axis - Hepatic Enzyme-Mediated BBB Protection
Hepatic Encephalopathy Hepatic encephalopathy (HE) represents the most studied model
Read more →
Graph neighborhood (30 nodes · 58 edges)
Click a neighbor to navigate · double-click opens in a new tab · open in full graph viewer
Related hypotheses
- Systemic IL-6–STAT3–Hepatic C3 Axis and BBB-Mediated Complement Translocation
Mechanistic Overview Systemic IL-6–STAT3–Hepatic C3 Axis and BBB-Mediated Complement Translocation starts ... reads: "## Mechanistic Overview Systemic IL-6–STAT3–Hepatic C3 Axis a…
- Biphasic Ketogenic Intervention Protocol
represents the rate-limiting enzyme in hepatic ketogenesis, catalyzing the condensation of acetyl ... minutes of neurological insult. This formulation bypasses hepatic ketogenesis…
- Peripheral Monocyte/Macrophage Infiltration Mimicking Microglial Loss
barrier integrity. The molecular cascade begins with hepatic injury-induced release of damage-associated molecular ... like receptors (TLRs) and purinergic receptors on hepatic K…
- LXRα-Selective Agonism to Enhance Hepatic APOE Secretion and Peripheral Cholesterol Clearance
therapeutic approach for addressing dyslipidemia by targeting hepatic cholesterol homeostasis rather than microglial cholesterol accumulation ... lipid metabolism. Selective LXRα …
- LXRβ-Selective Agonism as a Precision Therapeutic for APOE4-Driven Myelin Deficits
agonist development was discontinued due to hepatic steatosis and hypertriglyceridemia in humans; therapeutic window proved ... selective LXR modulators failed to fully dissociate…